MedPath

NMPA Approvals

Chinese National Medical Products Administration approved drug approval numbers and registration information

National Medical Products Administration
China
166,322 Approvals
Showing 341 to 360 of 166,322 approvalsPage 18 of 8317

Cisatracurium Besylate Injection

Approval Number: 国药准字H20254236
Registration: May 20, 2025

Tacrolimus Ointment

Approval Number: 国药准字H20254216
Registration: May 20, 2025

Sacubitril Allisartan Calcium Tablets

Approval Number: 国药准字H20250018
Registration: May 20, 2025

Lemborexant Tablets

Approval Number: 国药准字HJ20250057
Registration: May 20, 2025

Eldecalcitol Soft Capsules

Approval Number: 国药准字H20254208
Registration: May 20, 2025
广东江正药业有限公司

Sacubitril Allisartan Calcium Tablets

Approval Number: 国药准字H20250017
Registration: May 20, 2025

Atosiban Acetate Injection

Approval Number: 国药准字H20254203
Registration: May 20, 2025

Metoprolol Tartrate Injection

Approval Number: 国药准字H20254231
Registration: May 20, 2025

Tolvaptan Orally Disintegrating Tablets

Approval Number: 国药准字H20254194
Registration: May 20, 2025

Vonoprazan Fumarate Tablets

Approval Number: 国药准字H20254207
Registration: May 20, 2025

Piracetam Injection

Approval Number: 国药准字H20254229
Registration: May 20, 2025

Choline Fenofibrate Sustained-release Capsules

Approval Number: 国药准字H20254220
Registration: May 20, 2025

Norepinephrine Bitartrate Injection

Approval Number: 国药准字H20254192
Registration: May 20, 2025

Valsartan and Amlodipine Tablets (II)

Approval Number: 国药准字H20254234
Registration: May 20, 2025

Azithromycin for Injection

Approval Number: 国药准字H20254211
Registration: May 20, 2025

Levofloxacin and Sodium Chloride Injection

Approval Number: 国药准字H20254212
Registration: May 20, 2025

Neostigmine Methylsulfate Injection

Approval Number: 国药准字H20254190
Registration: May 20, 2025

Pramipexole Dihydrochloride Tablets

Approval Number: 国药准字H20254232
Registration: May 20, 2025

Sodium Fluoride [18F] Injection

Approval Number: 国药准字H20254224
Registration: May 20, 2025

Progesterone Soft Capsules

Approval Number: 国药准字H20254198
Registration: May 20, 2025

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.